✓ Betaling met creditcard hersteld — veilige afrekening via Privacy Shield

Amlip

Amlip is Cipla’s amlodipine 2.5 / 5 mg tablets — starter-to-maintenance DHP calcium-channel blocker. 2.5 mg is the low-starter strength for elderly, small body size, or hepatic impairment. 5 mg is standard maintenance for hypertension and angina. Once daily; gradual smooth onset; no reflex tachycardia.

Medisch beoordeeld door Morgan Ellis — Apotheekonderzoeker · 8 jaar ervaring  · Laatst beoordeeld: mei 2026

Meer kopen, meer besparen Prijs per tablet
Selecteer een sterkte hierboven om de verpakkingprijzen te zien.
Versleutelde checkout
Crypto betaalt 10% minder
Discrete wereldwijde levering
1.400+ klanten · 50+ landen

⚡ Quick Answer — What is Amlip?

Amlip is een 2.5 / 5 mg amlodipine tablet from Cipla — a third-generation dihydropyridine calcium-channel blocker (CCB). Introduced 1990 (Pfizer as Norvasc / Istin). The reference DHP for hypertension worldwide. Plasma half-life 35-50 hours — the longest of any CCB and one of the longest half-lives in cardiovascular medicine. Amlodipine’s extremely long half-life means: (1) dose missed by a day has minimal effect, (2) gradual smooth onset with no reflex tachycardia (unlike short-acting nifedipine), (3) no need for sustained-release formulations, (4) can be paired safely with any other antihypertensive class including beta-blockers. Typical hypertension dose: 5 mg once daily (2.5 mg if elderly, small body size, or hepatic impairment); target 5-10 mg once daily. Main side effects: ankle (peripheral) oedema, flushing, headache from vasodilation, reflex tachycardia (blunted by amlodipine’s long half-life; common with IR nifedipine). Safe to combine with beta-blockers, ACE inhibitors, ARBs, and thiazides (unlike non-DHP CCBs). Pregnancy: nifedipine MR is pregnancy-safe and often first-line; amlodipine is reasonable second option.

Wat u krijgt bij MedsBase: WHO-GMP gecertificeerde fabrikant · Discrete verpakking · Wereldwijde verzending · 1.400+ geverifieerde klantbeoordelingen

📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.

Waarom bestellen bij MedsBase

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.

What Is Amlip?

Amlip is an oral 2.5 / 5 mg amlodipine tablet from Cipla, supplied in 30-180 tablets. Introduced 1990 (Pfizer as Norvasc / Istin). The reference DHP for hypertension worldwide.

Amlodipine belongs to the dihydropyridine calcium-channel blocker subclass, distinguished from the non-dihydropyridines (diltiazem, verapamil) by its selective action on vascular smooth muscle with minimal direct cardiac effect. This selectivity profile is clinically important: DHPs can be combined safely with beta-blockers (the combination is standard in angina), while non-DHPs cannot (additive bradycardia/heart-block risk).

How Amlodipine Works

Calcium-channel blockers bind L-type voltage-gated calcium channels and reduce calcium influx into the cell during depolarisation. In arterial smooth muscle, reduced calcium entry means less actin-myosin interaction and direct arterial vasodilation — lowering systemic vascular resistance and blood pressure.

Dihydropyridines are ~10-fold more potent on vascular smooth muscle than on cardiac muscle — so the dominant clinical effect is vasodilation, with minimal direct suppression of cardiac contractility or conduction. The body’s baroreflex can trigger mild reflex tachycardia after fast-onset vasodilation; amlodipine’s very long onset eliminates this effect clinically.

Onset of clinical effect: gradual onset over 6-12 hours, full effect at 7-8 days.

Approved and Evidence-Based Uses

  • Uncomplicated hypertension — often first-line, particularly for Black patients and those over 55 (NICE, AHA)
  • Hypertension + stable angina (dual indication)
  • Prinzmetal / vasospastic angina — first-line
  • Raynaud’s phenomenon
  • Hypertension in heart failure with preserved ejection fraction (HF-pEF) — safer than non-DHP CCBs which are contraindicated in HF-REF
  • Hypertension in pregnancy — not first-line but reasonable second option after methyldopa / labetalol / nifedipine MR

Pivotal trial evidence: ASCOT-BPLA (2005) — perindopril + amlodipine beat atenolol + thiazide for CV outcomes in hypertension, establishing the modern preference for CCB + ACEi/ARB over beta-blocker + thiazide. VALUE (2004) — amlodipine-based therapy had slight advantage over valsartan-based therapy on stroke+MI endpoints, driven largely by faster BP drop. ALLHAT (2002) — amlodipine equivalent to chlorthalidone for most outcomes, better than lisinopril for stroke in black patients.

Amlip Dosage

Hypertension:

  • Startdosis: 5 mg once daily (2.5 mg if elderly, small body size, or hepatic impairment)
  • Target dose: 5-10 mg once daily
  • Maximum: 10 mg once daily
  • Titrate every 1-2 weeks based on BP response and tolerability (particularly oedema)

Angina: 5-10 mg once daily for chronic stable and vasospastic angina

Administration: once daily (or twice daily for IR nifedipine formulations). Swallow whole — do NOT crush or split extended-release formulations (delivers an IR dose with risk of hypotension). Take with or without food.

Discontinuation: no specific withdrawal syndrome; can be stopped without taper. BP will return to pre-treatment levels within 1-2 weeks.

Bijwerkingen

Common (>5%, mostly mild and transient):

  • Peripheral (ankle) oedema — Peripheral (ankle) oedema from pre-capillary vasodilation — dose-related (up to 25% at 10 mg/day). Not from fluid overload; does not respond to diuretics. Management: reduce dose, combine with an ACE inhibitor or ARB (which neutralise the oedema via balanced pre-and-post-capillary vasodilation), or switch to a non-DHP CCB (diltiazem, verapamil) if the heart-rate effect is acceptable.
  • Flushing (warm face and upper body)
  • Headache (particularly at start of therapy; usually adapts within 2-4 weeks)
  • Minor palpitations (less common than with short-acting nifedipine)
  • Dizziness, postural hypotension
  • Vermoeidheid
  • Mild constipation (less than non-DHPs)

Minder vaak voorkomend:

  • Rash, pruritus
  • Nausea, abdominal discomfort
  • Erectile dysfunction (rare)
  • Liver enzyme elevations (usually mild, reversible)
  • Rare reports of photosensitivity

Contraindications & Cautions

  • Known hypersensitivity to amlodipine or dihydropyridine class
  • Cardiogenic shock
  • Severe aortic stenosis (can cause critical hypotension)
  • Unstable angina or MI within 1 month (DHPs other than amlodipine)
  • Obstructive hypertrophic cardiomyopathy (reduces outflow gradient dynamically)
  • Severe hepatic impairment (all DHPs are hepatically metabolised)

Pregnancy: amlodipine is not first-line in pregnancy but has reassuring observational data; a reasonable second-line choice if labetalol, methyldopa, and nifedipine MR are ineffective or contraindicated.

Breastfeeding: small amounts in breast milk; generally considered acceptable with infant monitoring.

Geneesmiddelinteracties

  • Grapefruitsap — inhibits CYP3A4 metabolism; can raise plasma levels of amlodipine and particularly nifedipine/nimodipine by 2-3×. Avoid on treatment days, or use consistently if at all.
  • Sterke CYP3A4-remmers (ketoconazole, itraconazole, clarithromycin, ritonavir, cobicistat) — raise CCB plasma levels; reduce dose or avoid
  • Strong CYP3A4 inducers (rifampicin, phenytoin, carbamazepine, St John’s wort) — reduce CCB plasma levels; may need dose increase
  • Simvastatin — amlodipine modestly increases simvastatin exposure; cap simvastatin at 20 mg/day when combined
  • Bètablokkers — DHPs combine safely with beta-blockers (the combination is standard in angina — beta-blocker blunts reflex tachycardia, CCB provides vasodilation). Distinct from non-DHP CCBs (diltiazem, verapamil) which should NOT be combined with beta-blockers.
  • Other antihypertensives — generally complementary; monitor BP
  • Sildenafil / tadalafil (PDE5 inhibitors for erectile dysfunction) — additive hypotension; caution particularly at high CCB doses

Calcium-Channel Blocker Class at a Glance

CCBKlasseNiche
Amlodipine (Amlode, Amlip)DHP (3rd gen)Reference DHP; once-daily HTN + angina; ASCOT evidence
Nifedipine (Depin, Nicardia Retard, Cardipin)DHP (1st gen)Pregnancy-safe MR; tocolysis; must use ER formulations for chronic HTN
Nimodipine (Nimodip)DHP (cerebrovascular)Subarachnoid haemorrhage vasospasm prevention — NOT for routine HTN
Diltiazem (Dilzem, Dilzem CD)Non-DHP (benzothiazepine)HTN + rate control + angina; moderate cardiac effect
Verapamil (Calaptin 40, Calaptin SR)Non-DHP (phenylalkylamine)Strongest cardiac effect; SVT, AF rate, cluster headache

DHP vs non-DHP — why it matters: DHPs (amlodipine, nifedipine) act selectively on arterial smooth muscle with minimal cardiac effect — safe to combine with beta-blockers. Non-DHPs (diltiazem, verapamil) slow AV nodal conduction and reduce cardiac contractility — do NOT combine with beta-blockers (additive bradycardia, heart block, acute heart failure risk). If your patient is already on a beta-blocker, use a DHP.

Opslag

Store Amlip below 25°C. Protect from light. Keep out of reach of children.

Veelgestelde vragen

Why have my ankles started swelling after Amlip?

Peripheral oedema is a class effect of dihydropyridines, caused by pre-capillary arteriolar dilation that raises hydrostatic pressure in the lower-leg venules. It is NOT fluid overload and does NOT respond to diuretics. Management options: (1) reduce the CCB dose; (2) add an ACE inhibitor or ARB which balances pre- and post-capillary vasodilation and eliminates the oedema mechanism (often the preferred solution); (3) switch to a non-DHP CCB (diltiazem, verapamil) if rate-related side effects are acceptable; (4) leg elevation and compression stockings as adjuncts.

How long does Amlip take to lower blood pressure?

Gradual onset — measurable BP reduction within 24-48 hours; full effect at 7-8 days. Amlodipine’s extremely long half-life (35-50 h) gives one of the smoothest BP profiles in cardiovascular medicine.

Can I take Amlip with a beta-blocker?

Yes — DHPs combine safely with beta-blockers. The combination is standard in angina: the DHP vasodilates and reduces myocardial oxygen demand; the beta-blocker blunts the reflex tachycardia. This is different from non-DHP CCBs (diltiazem, verapamil) which should NOT be combined with beta-blockers due to additive bradycardia and heart-block risk.

Can I eat grapefruit on Amlip?

Grapefruit (juice and fresh fruit) inhibits CYP3A4 metabolism and can raise amlodipine plasma levels by 2-3×, increasing the risk of hypotension, dizziness, and oedema. Best practice: avoid grapefruit/juice while on CCBs, or consume consistently (your dose is titrated to BP response; sporadic grapefruit disrupts that).

Is Amlip safe in pregnancy?

Amlodipine is not first-line in pregnancy but has reassuring observational data; a reasonable second-line if labetalol, methyldopa, and nifedipine MR are ineffective or contraindicated. Discuss with your obstetrician.

Can I combine Amlip with my other BP medications?

Yes — DHP CCBs combine well with ACE-remmers (ramipril, lisinopril), ARBs (losartan, telmisartan, olmesartan), beta-blockers (bisoprolol, metoprolol), and thiazide diuretics (HCTZ). The ACEi/ARB + CCB combination is particularly useful because it eliminates the ankle oedema side effect.

Where can I buy Amlip online?

You can buy Amlip (amlodipine 2.5 / 5 mg, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.

Related Antihypertensives on MedsBase

⚕ Medisch disclaimer. This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Hypertension, heart failure, and arrhythmias require diagnosis, monitoring, and dose individualisation by a doctor — always use beta-blockers under medical guidance.

Gerelateerde alternatieven

Andere producten in Chronische aandoeningen die klanten ook bekijken:

Meer opties in medicatie tegen hoge bloeddruk

Gerangschikt op recente bestelvolumes van MedsBase — wat andere klanten in deze categorie kiezen.

Sterkte

2,5 mg, 5 mg

Hoeveelheid

30 Tabletten, 60 Tabletten, 90 Tabletten, 180 Tabletten

Beoordelingen

Er zijn nog geen beoordelingen

Plaats een beoordeling
Amlip Amlip
Beoordeling*
0/5
* Beoordeling is verplicht
* Antwoord is verplicht
Jouw beoordeling
* Beoordeling is verplicht
Naam
* Naam is verplicht
Voeg foto's of video toe aan je beoordeling

Vragen & antwoorden

Stel een vraag
Amlip Amlip
Uw vraag
* Vraag is verplicht
Naam
* Naam is verplicht
Er zijn nog geen vragen